In keeping with lvPPA being associated with underlying AD pathology, the findings of increased CCL2, CCL3, and CX3CL1 in this group parallel previous studies in those with a typical AD clinical presentation [13–18]. The gene discussed is CX3CL1; the disease is Alzheimer disease.